申请人:Weingarten M. David
公开号:US20090270454A1
公开(公告)日:2009-10-29
Provided are compounds, pharmaceutical compositions and methods of treatment or prophylaxis of an inflammatory condition, in particular asthma. The compounds are of the general Formula I, or a pharmaceutically acceptable salt, ester, prodrug or derivative thereof:
wherein:
X and Y are independently selected from —CH
2
— or —CH
2
—CH
2
—; Z is selected from S(O)
m
or Se(O)
m
and m is 0, 1 or 2; R
1
is optionally substituted heteroaryl or heterocyclic; R
2
is selected from the group consisting of hydrogen, C
1
-C
6
straight alkyl, and C
1
-C
6
branched alkyl, wherein all may be optionally substituted; and R
3
and R
4
are alkyl.
提供了化合物、药物组合物及治疗或预防炎症状况,特别是哮喘的方法。该化合物属于一般式I,或其药学上可接受的盐、酯、前药或衍生物:其中,X和Y独立地选择自—CH2—或—CH2—CH2—;Z选择自S(O)m或Se(O)m,m为0、1或2;R1为可选择的取代杂环芳基或杂环基;R2选择自氢、C1-C6直链烷基和C1-C6支链烷基,其中所有基团均可选择性地取代;R3和R4为烷基。